Spinal Fusion Devices Market Size & Share to See Modest Growth Through 2026

Spinal Fusion Devices Market Size & Share to See
Modest Growth Through 2026
Spinal Fusion Devices Market, by Device Type (Spinal Plating Systems,
Interbody Cages, and Pedicle Screw Systems), by Procedure Type (Cervical
Spine, Thoracic spine, and Lumbar Spine), by End User (Hospitals, Ambulatory
Surgical Center, Orthopedic Center, and Others), and by Region - Global
Forecast to 2025
Spinal fusion devices are used in spinal surgeries for patients suffering from various spinal diseases
such as degenerative disc disease (DDD) and herniated disc. Spinal fusion devices are implanted into
the spinal cord of the patient. The U.S. Food & Drug Administration (FDA) has placed spinal fusion
devices under Class II of medical devices category. Moderate to severe spine problems need to be
treated with surgical approach such as spinal fusion wherein the spinal vertebrae are either removed
and fixated with implants or fused with the help of various fusion methods. Quality of life can be
improved by spinal fusion surgeries. Rising prevalence of spinal cord diseases is expected to increase
adoption of these surgeries. Click To Read More On Spinal Fusion Devices Market.
Market Dynamics
Frequent approval from regulatory bodies to latest spinal fusion devices is expected to be the major
driver for growth of global spinal fusion devices market over the forecast period. In 2016, Spineart
Geneva SA received US Food and Drug Administration (FDA) clearance for its first range of titanium
interbody, named - JULIET Ti PO, OL and TL interbody systems. The JULIETTi PO, OL and TL
interbody systems are the range of titanium interbody implants. It include a full range of sizes to for
diverse anatomies. The smooth bullet-shaped nose, lateral sides and chamfers of the implant are
polished to preserve endplates, nerve roots, and soft tissues during insertion. The Ti-LIFE Technology
micro-porous scaffold mimics the bone trabecular structure, which enables cell colonization and
promotes bone ingrowth. In 2016, Centinel Spine, Inc. received U.S. FDA approval for STALIF L
Minimally-Invasive Lateral Integrated Interbody System. It has advantages in minimally-invasive
spinal fusion surgery. Furthermore, increasing prevalence of spinal disorder is also expected to increase
demand for spinal fusions devices and hence is expected to drive spinal fusion devices market growth
in near future.
Ask For Sample Copy Of This Business Research Report :
https://www.coherentmarketinsights.com/insight/request-sample/1211
Rapid product launch and frequent approval of novel spinal fusion devices are expected to drive
growth of the global spinal fusion market
In 2015, Aesculap Implant Systems, a division of B. BRAUN MELSUNGEN AG, launched Modulift
Vertebral Body Replacement System (VBR). It is the latest generation of expandable cage technology.
In 2017, Stryker’s Spine division launched Serrato pedicle screw, a unique dual-lead screw intended for
use in the non-cervical spine. In 2016, Stryker launched Aero-C Cervical Stability System at the
meeting of the American Academy of Orthopedic Surgeons in Orlando. Entry of these novel products
in market is expected to support the growth of global spinal fusion devices market in near future.
Furthermore, frequent approvals of innovative products is also expected to drive market growth.
Competitive Landscape
Key players operating in global spinal fusion devices market include Zimmer Biomet Holdings, Inc.,
Inc., Stryker Corporation, Inc., Exactech, Inc., Orthofix International N.V., Globus Medical, Inc.,
NuVasive, Inc., Medtronic Plc., Depuy Synthes, B. Braun Melsungen AG, Wenzel Spine, Inc., K2M
Group Holdings, Inc., Centinel Spine, Inc., and Spineart Geneva SA.
Increasing prevalence of spinal deformities is expected to drive growth of the global spinal fusion
device market
Factors responsible for spinal deformities include weight, diet, smoking, and other lifestyle factors.
Early onset of degenerative spinal changes is attributed to the toxins in cigarette smoke damaging the
cartilage of spine. According to World Health Organization (WHO), more than 1.1 billion people
smoked tobacco in 2015 worldwide. According to a study published in SpineUniverse in 2017, disc
herniation is the most common indication for spinal surgery, and around 75% of all spinal surgeries
were performed for herniated disc. Increasing prevalence of spinal deformities due to unhealthy
lifestyle and high chances of disc herniation are expected to drive growth of the spinal fusion devices
market in near future.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]

Spinal fusion devices are used in spinal surgeries for patients suffering from various spinal diseases such as degenerative disc disease (DDD) and herniated disc. Spinal fusion devices are implanted into the spinal cord of the patient.

Download Report